Physician profile
Alok Krishna
NPI 1437100898
$2,817.11
in general payments reported to CMS, 2019-2025
31 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $513 · 2021: $305 · 2022: $233 · 2023: $244 · 2024: $251 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $377.10 | 2019-2025 | Spravato |
| Pfizer INC. | $223.74 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $216.36 | 2019-2024 | Xifaxan |
| Sunovion Pharmaceuticals INC. | $199.35 | 2019-2021 | |
| Abbvie INC. | $186.20 | 2021-2024 | |
| Orexo US, INC. | $179.58 | 2019-2020 | |
| Glaxosmithkline, LLC. | $143.86 | 2019-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $136.84 | 2019-2021 | |
| Medtronic Vascular, INC. | $132.26 | 2019 | |
| Boston Scientific Corporation | $102.42 | 2025 | Infinion 16 |
| Abbott Laboratories | $100.00 | 2022 | |
| Merck Sharp & Dohme LLC | $98.76 | 2019-2021 | |
| Dynasplint Systems INC. | $71.59 | 2019 | |
| Novo Nordisk INC | $60.34 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $59.68 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.03 | 2019-2020 | |
| Almatica Pharma LLC | $54.32 | 2021-2022 | |
| Gilead Sciences, INC. | $53.56 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $51.74 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $46.56 | 2020-2021 | |
| Mdd US Operations, LLC | $44.49 | 2019 | |
| Exact Sciences Corporation | $43.00 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lundbeck LLC | $33.77 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $24.46 | 2025 | Auvelity |
| Braeburn INC. | $23.98 | 2025 | Brixadi |
| Biohaven Pharmaceutical Holding Company LTD. | $23.32 | 2022 | |
| Uswm, LLC | $18.67 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.42 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2019 | |
| Biodelivery Sciences International, INC. | $12.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.